Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Greene

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Toxicology|May 17, 2015
(Q)SAR: A Tool for the ToxicologistThomas Steinbach, Samantha Gad-McDonald, Naomi Kruhlak, et al.
Drug Discovery Today|January 24, 2014
Finding the rules for successful drug optimisationIskander Yusof, Falgun Shah, Tatsu Hashimoto, et al.
Pharmaceutical Research|August 8, 2023
Accelerating Drug Product Development and Approval: Early Development and EvaluationAnnette Bak, Rubi Burlage, Nigel Greene, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 15, 2012
The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylationRussell T Naven, Rachel Swiss, Jacquelyn Klug-McLeod, et al.
Regulatory Toxicology and Pharmacology : RTP|February 9, 2006
The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug developmentKrista L Dobo, Nigel Greene, Michelle O Cyr, et al.
Journal of Chemical Information and Modeling|April 13, 2007
Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potentialDennis J Pelletier, Daniel Gehlhaar, Anne Tilloy-Ellul, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studiesNigel Greene, Michael D Aleo, Shirley Louise-May, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 21, 2024
Perspectives on the use of machine learning for ADME prediction at AstraZenecaErik Gawehn, Nigel Greene, Filip Miljković, et al.
Journal of Cheminformatics|September 27, 2025
PKSmart: an open-source computational model to predict intravenous pharmacokinetics of small moleculesSrijit Seal, Maria-Anna Trapotsi, Manas Mahale, et al.
Chemical Research in Toxicology|June 18, 2010
Developing structure-activity relationships for the prediction of hepatotoxicityNigel Greene, Lilia Fisk, Russell T Naven, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Toxicology|May 17, 2015
(Q)SAR: A Tool for the ToxicologistThomas Steinbach, Samantha Gad-McDonald, Naomi Kruhlak, et al.
Drug Discovery Today|January 24, 2014
Finding the rules for successful drug optimisationIskander Yusof, Falgun Shah, Tatsu Hashimoto, et al.
Pharmaceutical Research|August 8, 2023
Accelerating Drug Product Development and Approval: Early Development and EvaluationAnnette Bak, Rubi Burlage, Nigel Greene, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 15, 2012
The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylationRussell T Naven, Rachel Swiss, Jacquelyn Klug-McLeod, et al.
Regulatory Toxicology and Pharmacology : RTP|February 9, 2006
The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug developmentKrista L Dobo, Nigel Greene, Michelle O Cyr, et al.
Journal of Chemical Information and Modeling|April 13, 2007
Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potentialDennis J Pelletier, Daniel Gehlhaar, Anne Tilloy-Ellul, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studiesNigel Greene, Michael D Aleo, Shirley Louise-May, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 21, 2024
Perspectives on the use of machine learning for ADME prediction at AstraZenecaErik Gawehn, Nigel Greene, Filip Miljković, et al.
Journal of Cheminformatics|September 27, 2025
PKSmart: an open-source computational model to predict intravenous pharmacokinetics of small moleculesSrijit Seal, Maria-Anna Trapotsi, Manas Mahale, et al.
Chemical Research in Toxicology|June 18, 2010
Developing structure-activity relationships for the prediction of hepatotoxicityNigel Greene, Lilia Fisk, Russell T Naven, et al.
Pageof 5